Kissei Pharmaceutical Co Ltd (4547) Stock Price & News

4547:TYO

Kissei Pharmaceutical Co Ltd

¥3,885.00

+1.44%

(+55.00) 1D

Nov 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4547...

Open

¥3,860

High

¥3,885

Low

¥3,830

Mkt. cap

180.82B

Avg. vol.

85.82K

Volume

77.00K

Dividend

3.22%

Quarterly dividend

¥31

Ex-dividend date

Mar 30, 2027

P/E ratio

14.40

52-wk high

¥5,040

52-wk low

¥3,500

EPS

¥270

Shares outstanding

46.72M

No. of employees

Open

¥3,860

High

¥3,885

Low

¥3,830

Mkt. cap

180.82B

Avg. vol.

85.82K

Volume

77.00K

Dividend

3.22%

Quarterly dividend

¥31

Ex-dividend date

Mar 30, 2027

P/E ratio

14.40

52-wk high

¥5,040

52-wk low

¥3,500

EPS

¥270

Shares outstanding

46.72M

No. of employees

Related stocks

ASKA Pharmaceutical Holdings Co Ltd

¥2,160.00

-1.37%

4502

Takeda Pharmaceutical Co Ltd

¥6,926.00

+1.48%

4521

Kaken Pharmaceutical Co Ltd

¥3,825.00

-0.39%

News stories

From web sources and news partners

TradingKey

6 hours ago

S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months

Foreign Policy Journal

5 hours ago

Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade

24/7 Wall St.

9 hours ago

He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076

Traders Union

13 hours ago

Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance

Profile

Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: Difelikefalin Fostamatinib Linzagolix Mitiglinide Remogliflozin etabonate Silodosin Tranilast In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia

About Kissei Pharmaceutical Co Ltd

CEOMutsuo Kanzawa

Employees1.79K

FoundedAug 9, 1946

HeadquartersMatsumoto, Nagano, Japan

SectorHealth Care

IndustryPharmaceutical industry

Websitekissei.co.jp

All values in JPY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	26.80B	24.77B	22.75B	22.11B
Cost of goods sold	14.50B	13.95B	12.96B	11.84B
Cost of revenue	14.50B	13.95B	12.96B	11.84B
Research and development expenses	-	22.52B	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9.15B	-15.41B	10.01B	9.68B
Operating expense	9.15B	10.07B	10.01B	9.68B
Total operating expenses	23.65B	24.02B	22.97B	21.52B
Operating income	3.16B	756.00M	-215.00M	599.00M
Other non operating income	10.00M	-10.00M	-34.50M	-78.00M
EBT including unusual items	4.20B	3.28B	3.33B	376.00M
EBT excluding unusual items	3.52B	948.00M	175.50M	661.00M
Income tax expense	915.00M	482.00M	704.00M	-122.00M
Effective tax rate	21.81%	14.68%	21.12%	-32.45%
Other operating expenses	-	129.00M	-	-
Net income	3.23B	2.76B	2.60B	468.00M
Net profit margin	12.05%	11.16%	11.41%	2.12%
Earnings per share	-	-	-	-
Interest and investment income	614.00M	224.00M	461.00M	193.00M
Interest expense	-7.00M	-8.00M	-9.50M	-11.00M
Net interest expenses	607.00M	216.00M	451.50M	182.00M
Depreciation and amortization charges	-	2.83B	-	-
EBITDA	4.31B	1.92B	972.50M	1.79B
Gain or loss from assets sale	-	-	-6.00M	-

Finance

Ask anything